Bicuspid aortic valves and TAVI: Is it still an exclusion criterion? State of the art and open issues

Paola Spatuzza, Neil Ruparelia, Azeem Latib

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Bicuspid aortic valve (BAV) is the most common congenital valvular disease, and is found in approximately 22% of all patients presenting with symptomatic severe aortic stenosis who are deemed high-risk for surgery. While BAV has historically been considered a relative contraindication to transcatheter aortic valve implantation, technical improvements in addition to greater operator confidence and experience has resulted in an increased number of percutaneous valve implantations in this patient group. Areas of uncertainty remain, but data from the literature suggests that the procedure can be safely performed in the setting of BAV, with results comparable to tricuspid aortic valve patients, at the expense of higher rates of short-term complications and postprocedural aortic regurgitation.

Original languageEnglish (US)
Pages (from-to)379-385
Number of pages7
JournalInterventional Cardiology
Volume7
Issue number4
DOIs
StatePublished - Aug 2015
Externally publishedYes

Keywords

  • aortic stenosis
  • bicuspid aortic valve
  • TAVI
  • transcatheter aortic valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Bicuspid aortic valves and TAVI: Is it still an exclusion criterion? State of the art and open issues'. Together they form a unique fingerprint.

Cite this